This study explores whether there is a simpler, globally applicable method for identifying statin-eligible patients for primary prevention that aligns with successful clinical trials, without relying on diverse and complicated risk calculation algorithms.

The selected recent analysis focused on uncovering new genetic connections and causal links between gastroesophageal reflux disease (GERD) and asthma. It studied how these two conditions might be related through genetics, helping us understand why some people may have both diseases and how they might affect each other.

This issue highlights a study included in Schizophrenia Bulletin. This study focused on creating a guideline for the use of metformin to prevent antipsychotic-induced weight gain (AIWG) in patients with severe mental illnesses such as schizophrenia and bipolar affective disorders.